Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoholic fatty liver disease: A nationwide analysis

BACKGROUND: Recent studies have revealed the endocannabinoid system as a potential therapeutic target in the management of nonalcoholic fatty liver disease (NAFLD). Cannabis use is associated with reduced risk for NAFLD, we hypothesized that cannabis use would be associated with less liver-related c...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Catherine J, Weiss, Stanley H, Nasir, Umair M, Pyrsopoulos, Nikolaos T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701971/
https://www.ncbi.nlm.nih.gov/pubmed/33312424
http://dx.doi.org/10.4254/wjh.v12.i11.993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701971/
https://www.ncbi.nlm.nih.gov/pubmed/33312424
http://dx.doi.org/10.4254/wjh.v12.i11.993

Ejemplares similares